Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Q4 2021 Rhythm Pharmaceuticals Inc Earnings Call Transcript

Mar 01, 2022 / 01:00PM GMT
Release Date Price: $8.49 (+11.42%)
Operator

Thank you for standing by, and welcome to the Rhythm Pharmaceuticals Fourth Quarter and Fiscal Year 2021 Financial Results Conference Call. (Operator Instructions) As a reminder, today's program may be recorded. I would now like to introduce your host for today's program, David Connolly with Rhythm Pharmaceuticals. Please go ahead.

David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications

Thank you, and good morning. I'm Dave Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via conference call, the accompanying slides are available and can be controlled on the Events section of the Investors section of our website at ir.rhythmtx.com. This morning, we issued a press release that provides fourth quarter and year-end 2021 financial results and a business update, which is also available on our website.

As listed on Slide 2 is our forward-looking statement. And I'll remind you that this call will contain certain remarks concerning future expectations, plans and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot